D Logar

907 total citations
17 papers, 509 citations indexed

About

D Logar is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, D Logar has authored 17 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 6 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in D Logar's work include Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Musculoskeletal synovial abnormalities and treatments (3 papers). D Logar is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Musculoskeletal synovial abnormalities and treatments (3 papers). D Logar collaborates with scholars based in Slovenia, United Kingdom and Austria. D Logar's co-authors include Blaž Rozman, Vita Dolžan, Petra Bohanec Grabar, Matija Tomšič, Tanja Kveder, Jurij Dobovišek, Franci Demšar, V. Jevtič, M. Kos-Golja and I. Watt and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Drug Metabolism and Disposition.

In The Last Decade

D Logar

17 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Logar Slovenia 13 336 101 95 85 63 17 509
S. Marzouk Tunisia 14 327 1.0× 48 0.5× 41 0.4× 255 3.0× 129 2.0× 94 652
KY Wong China 12 201 0.6× 58 0.6× 16 0.2× 129 1.5× 37 0.6× 24 383
Д. Е. Каратеев Russia 11 436 1.3× 21 0.2× 39 0.4× 188 2.2× 56 0.9× 174 667
P. Emery United Kingdom 15 432 1.3× 15 0.1× 57 0.6× 170 2.0× 77 1.2× 60 680
H Seifert Switzerland 5 132 0.4× 15 0.1× 50 0.5× 34 0.4× 44 0.7× 7 307
DJ Wallace United States 13 555 1.7× 29 0.3× 24 0.3× 348 4.1× 61 1.0× 24 732
Jean‐Frédéric Boyer France 10 323 1.0× 10 0.1× 39 0.4× 181 2.1× 109 1.7× 15 553
Johanna MW Hazes Netherlands 10 155 0.5× 60 0.6× 23 0.2× 203 2.4× 172 2.7× 11 421
Dina Zucchi Italy 14 412 1.2× 54 0.5× 15 0.2× 252 3.0× 60 1.0× 34 517
Ricardo Pineda-Tamayo Colombia 12 334 1.0× 13 0.1× 24 0.3× 215 2.5× 87 1.4× 26 613

Countries citing papers authored by D Logar

Since Specialization
Citations

This map shows the geographic impact of D Logar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Logar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Logar more than expected).

Fields of papers citing papers by D Logar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Logar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Logar. The network helps show where D Logar may publish in the future.

Co-authorship network of co-authors of D Logar

This figure shows the co-authorship network connecting the top 25 collaborators of D Logar. A scholar is included among the top collaborators of D Logar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Logar. D Logar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pirkmajer, Katja Perdan, Gerhard Thallinger, Saša Čučnik, et al.. (2012). Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease. Lupus. 21(2). 175–183. 26 indexed citations
2.
Grabar, Petra Bohanec, Luis J. Leandro‐García, Lucía Inglada‐Pérez, et al.. (2012). Genetic Variation in the SLC19A1 gene and Methotrexate Toxicity in Rheumatoid Arthritis Patients. Pharmacogenomics. 13(14). 1583–1594. 24 indexed citations
4.
Grabar, Petra Bohanec, D Logar, Matija Tomšič, Blaž Rozman, & Vita Dolžan. (2009). Genetic Polymorphisms Modifying Oxidative Stress Are Associated with Disease Activity in Rheumatoid Arthritis Patients. Disease Markers. 26(1). 41–48. 24 indexed citations
5.
Grabar, Petra Bohanec, D Logar, Matija Tomšič, Blaž Rozman, & Vita Dolžan. (2009). Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis.. PubMed. 27(2). 229–36. 32 indexed citations
6.
Grabar, Petra Bohanec, et al.. (2008). Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. European Journal of Clinical Pharmacology. 64(11). 1057–1068. 105 indexed citations
7.
Grabar, Petra Bohanec, et al.. (2008). Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients. European Journal of Clinical Pharmacology. 64(9). 871–876. 59 indexed citations
8.
Lainščak, Mitja, Alojzija Hočevar, D Logar, et al.. (2006). Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient. Clinical Rheumatology. 26(6). 1023–1024. 5 indexed citations
9.
Logar, D. (2002). The contribution of HLA-DQB1 coding and QBP promoter alleles to anti-Ro alone autoantibody response in systemic lupus erythematosus. British journal of rheumatology. 41(3). 305–311. 6 indexed citations
10.
Logar, D, Blanka Vidan‐Jeras, Aleš Ambrožič, et al.. (2002). The association of HLA-DR/DQ coding and QBP promoter allelic polymorphism with antiphospholipid antibody response in SLE. Arthritis Research. 4(Suppl 1). 23–23. 1 indexed citations
11.
Logar, D, et al.. (2000). Recurrent sepsis and seronegative arthritis in a patient with a selective IgG3 deficiency.. PubMed. 112(15-16). 735–7. 1 indexed citations
12.
Jevtič, V., I. Watt, Blaž Rozman, et al.. (1997). Contrast enhanced Gd-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patients.. PubMed. 15(2). 151–6. 25 indexed citations
13.
Jevtič, V., I. Watt, Blaž Rozman, et al.. (1996). Prognostic Value of Contrast Enhanced Gd-DTPA MRI for Development of Bone Erosive Changes in Rheumatoid Arthritis. Lara D. Veeken. 35(suppl 3). 26–30. 25 indexed citations
14.
Logar, D, Blaž Rozman, Alenka Vizjak, et al.. (1994). ARTERITIS OF BOTH CAROTID ARTERIES IN A PATIENT WITH FOCAL, CRESCENTIC GLOMERULONEPHRTTIS AND ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODIES. Lara D. Veeken. 33(2). 167–169. 14 indexed citations
15.
Pétrin, Jurij, Blaž Rozman, Primož Dolenc, et al.. (1993). The Dissociation of Arterial Hypertension and Lupus Glomerulonephritis in Systemic Lupus Erythematosus. Blood Pressure. 2(2). 108–112. 22 indexed citations
16.
Jevtič, V., I. Watt, Blaž Rozman, et al.. (1993). Precontrast and postcontrast (Gd-DTPA) magnetic resonance imaging of hand joints in patients with rheumatoid arthritis. Clinical Radiology. 48(3). 176–181. 31 indexed citations
17.
Logar, D, Tanja Kveder, Blaž Rozman, & Jurij Dobovišek. (1990). Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus.. Annals of the Rheumatic Diseases. 49(8). 627–629. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026